(Z)-2-Amino-9-((2,2-bis(hydroxymethyl)cyclopropylidene)methyl)-3,9-dihydro-6H-purin-6-one

Catalog No. :
ACOXPZ236
CAS No. :
632325-71-4
Molecular Formula :
C11H13N5O3
Molecular Weight :
263.26

IUPAC Name:(Z)-2-amino-9-((2,2-bis(hydroxymethyl)cyclopropylidene)methyl)-1,9-dihydro-6H-purin-6-one

(Z)-2-Amino-9-((2,2-bis(hydroxymethyl)cyclopropylidene)methyl)-3,9-dihydro-6H-purin-6-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$1167.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-2-Amino-9-((2,2-bis(hydroxymethyl)cyclopropylidene)methyl)-3,9-dihydro-6H-purin-6-one
IUPAC Name(Z)-2-amino-9-((2,2-bis(hydroxymethyl)cyclopropylidene)methyl)-1,9-dihydro-6H-purin-6-one
Molecular FormulaC11H13N5O3
Molecular Weight263.26
SMILESNC1=NC(C2=C(N(C=N2)/C=C3CC/3(CO)CO)N1)=O
InChI KeyKMUNHOKTIVSFRA-KXFIGUGUSA-N
SynonymMETHYL OLEATE (USP-RS) | 2-amino-9-[(Z)-[2,2-bis(hydroxymethyl)cyclopropylidene]methyl]-3H-purin-6-one | 2-amino-9-[(Z)-[2,2-bis(hydroxymethyl)cyclopropylidene]methyl]-1H-purin-6-one | Cymoxanil 100 microg/mL in Methyl-tert-butyl ether | ZSM-162 | ZSM-I62
CAS No.632325-71-4
PubChem CID135409256

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOXPZ236 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOXPZ236 route product structure diagram
    ACOXPZ236632325-71-4
Inquiry

2. ACOXPZ236 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOXPZ236 route product structure diagram
    ACOXPZ236632325-71-4
Inquiry

Comments (0)